| |
| |
|
| Insider
Information: |
Kennedy Giulia C |
| Relationship: |
Chief Scientific & Med... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
65,970 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,404,501 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
65,970 |
|
|
| Total
Value |
$1,404,501 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Veracyte, Inc. |
VCYT |
Chief Scientific & Med... |
2022-12-06 |
65,970 |
2019-02-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
49,400 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2020-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
96,862 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
100,018 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
300 |
81,574 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
80,764 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
42,412 |
79,987 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
10,702 |
71,055 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2019-08-12 |
4 |
AS |
$25.38 |
$717,095 |
D/D |
(28,257) |
48,037 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2019-08-13 |
4 |
AS |
$25.45 |
$118,088 |
D/D |
(4,640) |
48,037 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2019-09-03 |
4 |
AS |
$25.20 |
$380,656 |
D/D |
(15,031) |
48,037 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2019-09-04 |
4 |
AS |
$25.20 |
$7,458 |
D/D |
(296) |
47,449 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2019-11-27 |
4 |
AS |
$29.36 |
$108,534 |
D/D |
(3,697) |
47,449 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2019-12-03 |
4 |
AS |
$26.47 |
$405,663 |
D/D |
(15,327) |
46,862 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2019-12-05 |
4 |
AS |
$29.39 |
$964,142 |
D/D |
(32,803) |
46,862 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2020-03-03 |
4 |
AS |
$25.35 |
$834,798 |
D/D |
(32,881) |
81,274 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2020-06-03 |
4 |
AS |
$26.22 |
$282,809 |
D/D |
(10,786) |
80,487 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• • – |
2020-07-13 |
4 |
AS |
$28.82 |
$496,478 |
D/D |
(16,738) |
80,487 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• • – |
2020-07-31 |
4 |
AS |
$35.33 |
$706,694 |
D/D |
(20,000) |
80,487 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• • – |
2020-09-04 |
4 |
AS |
$30.05 |
$218,564 |
D/D |
(7,027) |
79,399 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• • – |
2020-10-06 |
4 |
AS |
$35.21 |
$88,025 |
D/D |
(2,500) |
79,399 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• • – |
2020-12-04 |
4 |
AS |
$55.78 |
$797,156 |
D/D |
(14,015) |
78,312 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-03-04 |
4 |
AS |
$47.11 |
$2,567,271 |
D/D |
(52,015) |
53,724 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-06-04 |
4 |
AS |
$33.28 |
$314,515 |
D/D |
(9,081) |
51,887 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-06-23 |
4 |
AS |
$39.75 |
$173,914 |
D/D |
(4,375) |
51,887 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-09-07 |
4 |
AS |
$50.52 |
$633,408 |
D/D |
(12,531) |
50,975 |
0 |
% |
|
80 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
